A glutathione-activated programmable DNA device for visual microRNA-210-enhanced photodynamic therapy of hypoxic lung cancer
Abstract
In this study, we construct a glutathione (GSH)-activated DNA nanodevice conjugated to a porphyrin-based metal–organic framework (PCN-224), creating an integrated theranostic platform for modulating hypoxia, enabling miRNA-210-specific imaging and enhancing photodynamic therapy (PDT).

Please wait while we load your content...